Skip to main content
S 839 112th Congress Senate Crime and Law Enforcement Drug trafficking and controlled substances

Combating Designer Drugs Act of 2011

Introduced: April 14, 2011 Introduced by: Klobuchar, Amy Democratic · Minnesota See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 28, 2011
Placed on Senate Legislative Calendar under General Orders. Calendar No. 121.
Jul 28, 2011
Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report.
Jul 28, 2011
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Apr 14, 2011
Read twice and referred to the Committee on the Judiciary.
Apr 14, 2011
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Combating Designer Drugs Act of 2011 - Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation which contains:

  • 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);
  • 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);
  • 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);
  • 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);
  • 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);
  • 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);
  • 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);
  • 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); or
  • 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).
What's happening now July 28, 2011

Placed on Senate Legislative Calendar under General Orders. Calendar No. 121.

 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 5
All 5 Democratic 3 Republican 2
R
Collins, Susan M.
Maine · Mar 8, 2012
 D
Coons, Christopher A.
Delaware · Sep 19, 2011
 D
Schumer, Charles E.
New York · Aug 1, 2011
 D
Blumenthal, Richard
Connecticut · Jul 20, 2011
 R
Grassley, Chuck
Iowa · Apr 14, 2011
Cite this page click to expand
APA
U.S. Congress. (2026). S. 839: Combating Designer Drugs Act of 2011. 112th Congress. Open America. https://openamerica.io/bill/112-S-839/
MLA
"S. 839: Combating Designer Drugs Act of 2011." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-S-839/.
Bluebook (legal)
S. 839, 112th Cong. (2026), https://openamerica.io/bill/112-S-839/.
Markdown link
[S. 839: Combating Designer Drugs Act of 2011](https://openamerica.io/bill/112-S-839/)
Report a problem